Barrow, Hanley, Mewhinney & Strauss’s Express Scripts Holding Company ESRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ESRX
ECM
BJL
BSPF
MYAM
AWM
W
ACA
UCFA
SBL
Barrow, Hanley, Mewhinney & Strauss's ESRX Position: Q4 2018 in Review
Barrow, Hanley, Mewhinney & Strauss sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 13,511,900 shares — an estimated $1.28B sold.
Barrow, Hanley, Mewhinney & Strauss first reported a position in ESRX in Q1 2016 and held it in 11 quarters. The position peaked at $1.3B in Q2 2017. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.
- Barrow, Hanley, Mewhinney & Strauss reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
- Barrow, Hanley, Mewhinney & Strauss sold 13,511,900 Express Scripts Holding Company shares in Q4 2018, an estimated $1.28B.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Express Scripts Holding Company in Q1 2016 and held it in 11 quarters.
- Barrow, Hanley, Mewhinney & Strauss's Express Scripts Holding Company position peaked at $1.3B in Q2 2017.
- 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q4 2018, filed 13 Feb 2019.